We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Mortality Rate Higher in Trauma Patients

By LabMedica International staff writers
Posted on 30 Mar 2011
A new study reports that after admission for trauma, adults experienced almost triple the cumulative mortality rate during the following three years, when compared to the general population. More...


Researchers at the University of Washington (Seattle, USA) conducted a retrospective cohort study of 124,421 injured adult patients from January 1995 to December 2008; patient data were obtained from the Washington State Trauma Registry, linked to death certificate data; of the total trauma patients, 7,243 died before hospital discharge, and 21,045 died following hospital discharge. The researchers used Kaplan-Meier and Cox proportional hazards models for data analysis

The results showed that cumulative mortality postinjury was 16% at three years, compared with the expected population cumulative mortality of 5.9%. In-hospital mortality improved during the 14-year study period from 8% to 4.9%, whereas long-term cumulative mortality increased from 4.7% to 7.4%. After adjustment for confounders, higher mortality rates were associated with discharge to a skilled nursing facility, regardless of patient age; adjusted hazard ratio leveled off at 2.02 for patients aged 46 to 55 years, dropping to 1.38 for patients older than 80 years. Other significant predictors of mortality after discharge included head injury score, injury severity score, mechanism of injury being a fall, and having Medicare or other government insurance. The study was published in the March 9, 2011, issue of the Journal of the American Medical Association (JAMA).

"Despite increases in federal regulations intended to improve skilled nursing facility care, there has been insufficient impact on quality or public reputation. Further investigation is needed to determine if more health clinician oversight, funding, or rehabilitation therapy is needed to improve the care of the patients at skilled nursing facilities following discharge for injury,” concluded lead author Giana Davidson, MD, MPH, and colleagues at the UW Harborview Injury Prevention and Research Center.

Related Links:

University of Washington





Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: The addition of Biocare’s complementary IHC antibody, reagent and instrument portfolio enhances Agilent’s immunohistochemistry offering (Photo courtesy of Biocare Medical)

Agilent Technologies Acquires Pathology Diagnostics Company Biocare Medical

Agilent Technologies (Santa Clara, CA, USA) has entered into a definitive agreement to acquire Biocare Medical (Pacheco, CA, USA), expanding its pathology portfolio through the addition of highly complementary... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.